MEDVi’s public disclosures make a useful distinction between an initial online screen and the clinician’s prescribing decision. Completing the assessment does not itself create a doctor-patient relationship with MEDVi or guarantee a prescription.
For someone concerned about charges before final approval, the order of these steps matters. This review focuses on that sequence, the payment questions to ask and the boundary between care coaching and licensed clinical decisions.
What the service actually offers
The site describes independent licensed clinical review through OpenLoop Health and states that a clinician determines prescription eligibility after checkout. It also describes coaching and nutrition support. These functions have different responsibilities: a preliminary screen, a support conversation and a prescription approval are not the same medical event.
Read the bill in full
Before authorizing payment, ask what the charge purchases at that stage and what is returned if no prescription is issued. Request the recurring total, selected term and any introductory-price conditions in writing. A guarantee or eligibility message should be read alongside its actual refund rules; this review has not tested a denial or refund transaction.
After the first order
The public care-coaching description may be helpful for everyday program questions. Ask how a symptom concern reaches the treating clinician and how that differs from contacting a coach or billing team. Refill decisions require current clinical information, so establish the secure channel for supplying it before the next order is due.
Keep a useful paper trail
For a concern about approval, save the screening result, the payment confirmation and the later clinical decision as separate documents. Use the dates to identify exactly where your request stands. If a prescription was not issued, ask support to reference the applicable refund term rather than assuming that the original screening message established treatment eligibility.
- What is charged before the prescribing clinician makes a decision?
- What refund applies if the clinician does not prescribe?
- How do clinical messages differ from coaching or account support?
Our reading of the trade-off
MEDVi’s disclosed sequence gives readers a concrete point to examine before purchase. The service may appeal to someone who wants coaching around an online treatment pathway, but that feature should not obscure the distinction between preliminary eligibility and an issued prescription. Compare the financial consequences of each stage, not only the initial assessment result.
What this review can establish
This is a desk review of published information, not a treatment trial, mystery-shopper order or verified complaint history. A provider’s website can establish what it advertises; it cannot show how reliably an individual request will be handled. We have not measured this service’s response time, refund performance or patient outcomes.
The prescription itself needs a separate clinical assessment. FDA-approved products and compounded preparations have different evidence and regulatory status. Compounded drugs are not FDA-approved, and a branded drug’s trial results cannot be assigned to a provider’s compound. Bring medication and safety questions to the prescribing clinician and dispensing pharmacist.
Turn the question into a useful message.
Choose a billing, delivery, account or treatment topic. Our support note builder gives you a short checklist and a draft to take to the right team.
Build your noteSources for this file
Provider sources describe advertised services; they do not establish delivery performance or patient outcomes. Medical sources support the educational context. Review date: 2026-10-05.